Literature DB >> 31769616

Spotted fever group rickettsiae canine serosurveillance near the US-Mexico border in California.

Irais Estrada1, Caroline Balagot2, Marian Fierro1, Paula Kriner1, Esmeralda Iniguez-Stevens2, Anne Kjemtrup3, Janet Foley4.   

Abstract

BACKGROUND: Dogs are vulnerable to pathogens transmitted by brown dog ticks. An epidemic of Rocky Mountain spotted fever (RMSF) is underway in Mexicali, a Mexican city bordering California affecting people and dogs; several human cases have been reported in California residents who travelled to Mexico. To evaluate risks of RMSF, we conducted seroprevalence surveys in Imperial County in 2016 and 2017 using dogs as sentinels.
METHODS: Blood was collected from 752 dogs and was tested for antibodies against R. rickettsii, E. canis and A. phagocytophilum (as a proxy for A. platys). Samples were considered seropositive to spotted fever group rickettsia (SFGR) if the R. rickettsia titre was ≥1:64 and seropositive to E. canis and A. phagocytophilum if the titre was ≥1:32. Owners provided information on dog age, exposure risks, health status and tick prevention. We assessed associations between SFGR seropositivity and driving distance to the nearest US-Mexico border crossing station, whether proximity to a border crossing increased likelihood of taking dogs across the border, and whether distance to the border was associated with seropositivity. Logistic regression was performed to assess relationships between the titre classes and other predictor variables.
RESULTS: 12.2% of dogs were seropositive against SFGR. Dogs close to the border were significantly more likely to be taken across the border and to be seropositive. Risk factors that increased seropositivity included owners seeing ticks on the dog (OR = 1.9), being an adult dog, travel to Mexico (OR = 3.0) and living in a rural area (OR = 4.0). There was statistically significant co-exposure to SFGR and Anaplasma spp.
CONCLUSION: Surveillance for brown dog tick-vectored pathogens can help identify dogs and people at risk for RMSF. Tick prevention, particularly in dogs, and surveillance of tick-borne pathogens can help prevent the spread of rickettsioses and other diseases in this dynamic border region.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  Rocky Mountain spotted fever; border disease; canine sentinel

Year:  2019        PMID: 31769616     DOI: 10.1111/zph.12666

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  4 in total

1.  Possible Association between Selected Tick-Borne Pathogen Prevalence and Rhipicephalus sanguineus sensu lato Infestation in Dogs from Juarez City (Chihuahua), Northwest Mexico-US Border.

Authors:  Diana M Beristain-Ruiz; Javier A Garza-Hernández; Julio V Figueroa-Millán; José J Lira-Amaya; Andrés Quezada-Casasola; Susana Ordoñez-López; Stephanie Viridiana Laredo-Tiscareño; Beatriz Alvarado-Robles; Oliver R Castillo-Luna; Adriana Floriano-López; Luis M Hernández-Triana; Francisco Martínez-Ibáñez; Ramón Rivera-Barreno; Carlos A Rodríguez-Alarcón
Journal:  Pathogens       Date:  2022-05-07

2.  An exploratory analysis of demography and movement patterns of dogs: New insights in the ecology of endemic Rocky Mountain-Spotted Fever in Mexicali, Mexico.

Authors:  Andrés M López-Pérez; Libertad Orozco; Oscar E Zazueta; Maria Fierro; Paola Gomez; Janet Foley
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 3.  A forty-year review of Rocky Mountain spotted fever cases in California shows clinical and epidemiologic changes.

Authors:  Anne M Kjemtrup; Kerry Padgett; Christopher D Paddock; Sharon Messenger; Jill K Hacker; Tina Feiszli; Michael Melgar; Marco E Metzger; Renjie Hu; Vicki L Kramer
Journal:  PLoS Negl Trop Dis       Date:  2022-09-15

4.  Novel Rickettsia Species Infecting Dogs, United States.

Authors:  James M Wilson; Edward B Breitschwerdt; Nicholas B Juhasz; Henry S Marr; Joao Felipe de Brito Galvão; Carmela L Pratt; Barbara A Qurollo
Journal:  Emerg Infect Dis       Date:  2020-12       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.